-
Shoppers Stop Share Price Gains 1.96% After Q1 Results Announced on 22 July 2026
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
Shoppers Stop share price gained 1.96% to Rs 383.05 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026. Full details, financials and outloo
-
Tokyo Finance Share Price Falls 0.05% After Q1 Results Announced on 21-22 July 2026
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
Tokyo Finance share price fell 0.05% to Rs 19.4 as of 23 July 2026, after the company announced its Q1 FY27 results on 21-22 July 2026. Full details, financials and outlook
-
Schneider Electric Infrastructure vs Siemens India Business Model: Which Electrical Equipment MNC Wins
- July 23, 2026
- Posted by: Kunal Singla
- Category: News
Schneider Electric Infrastructure vs Siemens India business model compares concentrated power distribution and grid automation equipment manufacturing against diversified industrial automation, mobility and energy MNC portfolio to see which electrical equipment mnc has better business model.
-
ABSL Overnight Direct Daily IDCW: NAV Today, Performance Review and Should You Invest?
- July 23, 2026
- Posted by: Neeraj Pandey
- Category: Mutual Funds
ABSL Overnight Direct Daily IDCW NAV, latest returns and full review including risks and how to invest.
-
IndusInd Bank Share Price Falls 4.96% After Q1 Results Announced on 22 July 2026 (after market hours)
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
IndusInd Bank share price fell 4.96% to Rs 1016.2 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026 (after market hours).
-
Alkem Laboratories vs Ajanta Pharma Business Model: Which Domestic Branded Formulations Wins
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
Alkem Laboratories vs Ajanta Pharma business model compares concentrated anti-infective and pain management branded formulations against concentrated ophthalmology therapeutic focus with meaningful export exposure to see which domestic branded formulations has better business model.
-
Indoco Remedies vs Ajanta Pharma Business Model: Which Domestic Branded Formulations Wins
- July 23, 2026
- Posted by: Kunal Singla
- Category: News
Indoco Remedies vs Ajanta Pharma business model compares domestic branded formulations combined with contract manufacturing exports against concentrated ophthalmology therapeutic focus with meaningful export exposure to see which domestic branded formulations has better business model.
-
ABSL Low duration Direct Growth: NAV Today, Performance Review and Should You Invest?
- July 23, 2026
- Posted by: Neeraj Pandey
- Category: Mutual Funds
ABSL Low duration Direct Growth NAV, latest returns and full review including risks and how to invest.
-
Ajanta Pharma vs Alembic Business Model: Which Domestic Branded Formulations Wins
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
Ajanta Pharma vs Alembic business model compares concentrated ophthalmology therapeutic focus with meaningful export exposure against diversified branded generics manufacturing across multiple therapeutic categories to see which domestic branded formulations has better business model.
-
ABSL Overnight Direct Weekly IDCW: NAV Today, Performance Review and Should You Invest?
- July 23, 2026
- Posted by: Neeraj Pandey
- Category: Mutual Funds
ABSL Overnight Direct Weekly IDCW NAV, latest returns and full review including risks and how to invest.